Clexane 40 mg/0.4 ml 2 Pre-Filled Syringe
Anticoagulant Injection To Prevent Blood Clots
To get online prescription you can take an online consultation
Quantity
Free shipping on all orders over99
Home Delivery or Pickup
Original products100% certified products from trusted sources.
Fast DeliveryFast delivery to your doorstep in record time.
Secure PaymentsSecure and protected payment methods to safeguard your data.- Key IngredientsEnoxaparin Sodium
- Product FormReady-To-Use Injection
- Package Size0.4 ml
- Caution & WarningsConsult A Physician Before Use.
- Storage ConditionsStore In The Refrigerator At 2-8°C.
- How To UseUse as directed by your doctor, subcutaneous injection.
- ConcernsPrevent Blood Clots
- Volume0.5 ml
1. What are the primary indications for CLEXANE 40MG use?
A1: It is used to prevent blood clot formation (such as Deep Vein Thrombosis - DVT) before and after surgery, or during prolonged periods of immobility due to illness. It is also used to treat existing clots and unstable angina.
2. How is the CLEXANE injection administered?
A2: The injection is usually given via subcutaneous injection, preferably in the abdomen area (about 5 cm away from the navel), with the injection site rotated each time. The injection site must not be rubbed after the injection.
3. Is CLEXANE used during pregnancy, and is it safe?
A3: Yes, it is used in some pregnancies (especially for those with a history of recurrent miscarriage or clotting issues) under strict medical supervision. It is generally considered safe for pregnancy because it does not cross the placenta.
4. What are the most common side effects?
A4: The most common side effects are local reactions at the injection site such as bruising, pain, or redness. These effects are usually mild.
5. When should its use be stopped or a doctor be consulted?
A5: A doctor must be consulted immediately if signs of unusual or severe bleeding appear (bleeding gums, dark/bloody stool, large and unexplained bruises), or in case of a severe allergy to the medication or heparin.